Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/0RA2 stock hub

LON/0RA2 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0RA2is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0RA2

In the news

Latest news · LON/0RA2

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROIC-127.4

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0RA2 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

163

Groups with data

Currency

EUR

Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	5
Employees Change	-1%
Employees Change Percent	-16.67
Enterprise value	EUR 63.8M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	FR0012432516
Last refreshed	2026-05-10
Market cap	EUR 12M
Price	EUR 0.26
Price currency	EUR
Rev Per Employee	1,312,705.6x
Sector	Healthcare
Sic	2836
Symbol	lon/0RA2
Website	https://www.poxelpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-97.63%
EV Earnings	-5.45x
EV/Sales	9.64x
P/B ratio	-0.23x
P/S ratio	1.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-22.92%
Gross margin	52.02%
Gross Profit	EUR 3.4M
Gross Profit Growth	7.85%
Gross Profit Growth Q	1,812.5%
Gross Profit Growth3 Y	1,485.15%
Gross Profit Growth5 Y	356.92%
Net Income	EUR -11.7M
Net Income Growth Quarters	3%
Pretax Margin	-178.42%
Profit Margin	-178.45%
Profit Per Employee	EUR -2.3M
ROA	-20.72
Roa5y	-38.83
ROCE	12.61
ROIC	-127.4
Roic5y	-242.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-29.11%
Cagr1y	-32.61%
Cagr3y	-26.5%
Cagr5y	-47.62%
EPS Growth Quarters	3
Revenue Growth	249.95x
Revenue Growth Q	87.87x
Revenue Growth Quarters	5x
Revenue Growth3 Y	56.94x
Revenue Growth5 Y	62.58x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.45
Assets	EUR 4.3M
Cash	EUR 1.8M
Current Assets	EUR 4.2M
Current Liabilities	EUR 16.4M
Debt	EUR 53.2M
Equity	EUR -52.6M
Interest Coverage	-0.16
Liabilities	EUR 56.9M
Long Term Assets	EUR 58,548
Long Term Liabilities	EUR 40.6M
Net Cash	EUR -51.4M
Net Cash By Market Cap	EUR -428
Tangible Book Value	EUR -52.6M
Tangible Book Value Per Share	EUR -0.98
WACC	13.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.26
Net Working Capital	EUR -1.3M
Quick ratio	0.23
Working Capital	EUR -12M
Working Capital Turnover	EUR -0.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-35.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-96.79%
1Y total return	-32.59%
200-day SMA	0.3
3Y total return	-60.29%
50-day SMA	0.26
50-day SMA vs 200-day SMA	50under200
5Y total return	-96.06%
All Time High	13.29
All Time High Change	-98.07%
All Time High Date	2016-05-26
All Time Low	0.12
All Time Low Change	108.88%
All Time Low Date	2024-12-10
ATR	0.01
Beta	1.54
Ch YTD	11.28
High	0.26
High52	0.83
High52 Date	2025-06-02
High52ch	-69.06%
Low	0.26
Low52	0.22
Low52 Date	2025-12-10
Low52ch	17.12%
Ma50ch	-1.27%
Price vs 200-day SMA	-15.29%
RSI	47.04
RSI Monthly	41.27
RSI Weekly	45.83
Sharpe ratio	0.24x
Sortino ratio	0.54
Total Return	-35.51%
Tr YTD	11.28
Tr1m	-5.35%
Tr1w	1.18%
Tr3m	-16.45%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -1.5M
Operating margin	-22.92

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	13,667,500.7
Shares Institutions	4.99%
Shares Qo Q	2.41%
Shares Yo Y	35.51%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	83,264.15x
Bv Per Share	-0.98
Ch10y	-96.79
Ch1m	-5.35
Ch1w	1.18
Ch1y	-32.59
Ch3m	-16.45
Ch3y	-60.29
Ch5y	-96.06
Ch6m	-3.02
Change	0.59%
Change From Open	-0.58
Close	0.26
Days Gap	1.18
Depreciation Amortization	21,625.8
Dollar Volume	22,040
Earnings Date	2026-06-15
EBIT	EUR -1.5M
EPS	EUR -0.22
F Score	4
Financing CF	-1,367,223
Fiscal Year End	December
Founded	2,009
Income Tax	EUR 1,714
Investing CF	23,144
Is Primary Listing	0
Last Earnings Date	2025-11-06
Last Report Date	2025-06-30
Ma150	0.28
Ma150ch	-7%
Ma20	0.26
Ma20ch	-2.36%
Net CF	-648,895
Next Earnings Date	2026-06-15
Open	0.26
P OCF Ratio	17.15
Position In Range	11.11
Ppne	865
Price Date	2026-05-08
Relative Volume	1.03x
Revenue	6,563,528x
SBC By Revenue	0.52x
Share Based Comp	34,288
Tax By Revenue	0.03x
Tr6m	-3.02%
Volume	85,926
Z Score	-31.48

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0RA2 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0RA2 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0RA2?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.0%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+35.5%

Negative means the company is buying back shares.

Technical

LON/0RA2 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.0

Neutral momentum band

Price vs 200-day MA

-15.3%

50/200-day relationship not available

Beta (5Y)

1.54

More volatile than the market

Sharpe ratio

0.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0RA2

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0RA2 stock rating?

lon/0RA2 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0RA2 analysis?

The full report lives at /stocks/lon/0RA2/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0RA2?

The latest report frames lon/0RA2 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0RA2 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.